Medtelligence
Medtelligence is dedicated to the creation of innovative, continuing medical education (CME) focusing on cardiovascular and cardiometabolic disease. Through the use of comprehensive, strategically aligned curricula, Medtelligence facilitates the sharing of research, knowledge, and clinical practice skills to engage medical practitioners to fulfill their commitment to lifelong professional development and ultimately improved patient care.
![]()
16-30 of 36
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
MinuteCE®Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
- advertisement
Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data
MinuteCE®Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data
The BeAT Goes On: New Data on Improving Symptoms in HFrEF Patients Using Novel Device Therapy
CME/CEThe BeAT Goes On: New Data on Improving Symptoms in HFrEF Patients Using Novel Device Therapy
Hyperkalemia in CKD and HFrEF…What Am I Missing?
CME/CEHyperkalemia in CKD and HFrEF…What Am I Missing?
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
CME/CEA Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
CME/CEImproving Symptoms in Patients with HFrEF Using Novel Device Therapy
- advertisement
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CEDirected Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CEKALMing the Itch: Improving QoL in Patients with CKD-aP























































































